Compare NeoGenomics Inc. Common Stock (NEO) vs Trade Desk Inc (TTD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NeoGenomics Inc. Common Stock vs Trade Desk Inc — how do they compare? NeoGenomics Inc. Common Stock trades at $17.17 (market cap $2.14B), while Trade Desk Inc trades at $12.18 (market cap $5.75B). The key difference: Trade Desk Inc is far larger — about 2.7× NeoGenomics Inc. Common Stock's market cap, and NeoGenomics Inc. Common Stock is trading nearer its 52-week high, Trade Desk Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and Trade Desk Inc for 73 Days on average.
| NEO | TTD | |
|---|---|---|
Market Cap | $2.14B | $5.75B |
Volume | 2,228,400 | 15,249,283 |
Sector | Health | Media |
52-Week High | $19.91 | $54.13 |
52-Week Low | $7.19 | $11.92 |
Typical Hold Time | 0 Days | 73 Days |
Enterprise Value | $2.44B | $4.70B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
The Trade Desk (TTD) trades at $12.17, down 68% year-to-date amid a bearish technical outlook and slowing revenue growth. Recent earnings show mixed results with a Q2 beat but a Q1 miss, while Q3 2026 guidance indicates a 12% revenue decline. The company maintains strong profitability margins and a low P/E ratio, but faces intense competition from tech giants and has announced workforce reductions.
The stock presents a high-risk opportunity with a consensus price target of $14.68 offering potential upside, though near-term headwinds from competition and index removal flows persist. Long-term prospects hinge on the company's ability to defend its open internet ad platform against Amazon and Google while restoring growth momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About NeoGenomics Inc. Common Stock
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →About Trade Desk Inc
The Trade Desk Inc is engaged in providing a technology platform for ad buyers. Through its cloud-based platform ad buyers can create, manage, and optimize data-driven digital advertising campaigns across ad formats and channels, including display, video, audio, in-app, native and social, on a multitude of devices. Its products include Data Management Platform, Cross-Device Targeting, Video Advertising, Mobile Advertising, and others.
Read more on TTD →
